125 related articles for article (PubMed ID: 11036249)
1. Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue.
Sato S; Miyauchi M; Takekoshi T; Zhao M; Kudo Y; Ogawa I; Kitagawa S; Fujita M; Takata T
Oral Oncol; 2000 Nov; 36(6):545-9. PubMed ID: 11036249
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of CD44, NANOG, OCT4, and BMI1 expression in tongue squamous cell carcinoma.
Rodrigues MFSD; Xavier FCA; Andrade NP; Lopes C; Miguita Luiz L; Sedassari BT; Ibarra AMC; López RVM; Kliemann Schmerling C; Moyses RA; Tajara da Silva EE; Nunes FD
Head Neck; 2018 Aug; 40(8):1759-1773. PubMed ID: 29607565
[TBL] [Abstract][Full Text] [Related]
3. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
[TBL] [Abstract][Full Text] [Related]
4. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
[TBL] [Abstract][Full Text] [Related]
5. Down-regulated expression of CD44 variant 6 in oral squamous cell carcinomas and its relationship to regional lymph node metastasis.
Kunishi M; Kayada Y; Yoshiga K
Int J Oral Maxillofac Surg; 1997 Aug; 26(4):280-3. PubMed ID: 9258720
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 amplification in tongue and cheek squamous cell carcinoma.
Mahdey HM; Ramanathan A; Ismail SM; Abraham MT; Jamaluddin M; Zain RB
Asian Pac J Cancer Prev; 2011; 12(9):2199-204. PubMed ID: 22296356
[TBL] [Abstract][Full Text] [Related]
7. Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma.
Kelner N; Rodrigues PC; Bufalino A; Fonseca FP; Santos-Silva AR; Miguel MC; Pinto CA; Leme AF; Graner E; Salo T; Kowalski LP; Coletta RD
Head Neck; 2015 Apr; 37(4):479-86. PubMed ID: 24677273
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma.
Gotoda T; Matsumura Y; Kondo H; Ono H; Kanamoto A; Kato H; Watanabe H; Tachimori Y; Nakanishi Y; Kakizoe T
Gut; 2000 Jan; 46(1):14-9. PubMed ID: 10601048
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 isoforms in squamous cell carcinoma of the border of the tongue: A correlation with histological grade, pattern of stromal invasion, and cell differentiation.
Fonseca I; Pereira T; Rosa-Santos J; Soares J
J Surg Oncol; 2001 Feb; 76(2):115-20. PubMed ID: 11223837
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Ong HS; Gokavarapu S; Xu Q; Tian Z; Li J; Ji T; Zhang CP
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1205-1219. PubMed ID: 28602571
[TBL] [Abstract][Full Text] [Related]
11. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma.
Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M
Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890
[TBL] [Abstract][Full Text] [Related]
12. Expression of cIAP-1 correlates with nodal metastasis in squamous cell carcinoma of the tongue.
Qi S; Mogi S; Tsuda H; Tanaka Y; Kozaki K; Imoto I; Inazawa J; Hasegawa S; Omura K
Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1047-53. PubMed ID: 18621506
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma.
Wada S; Yue L; Furuta I
Oral Oncol; 2004 Feb; 40(2):164-9. PubMed ID: 14693240
[TBL] [Abstract][Full Text] [Related]
14. [Multivariate analysis for prognostic predictors in the cN0 squamous cell carcinoma of the tongue].
Zhao H; Zeng ZY; Chen FJ; Xu GP; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2003 Feb; 22(2):206-9. PubMed ID: 12600302
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of RUNX3 protein expression in tongue squamous cell carcinoma and its association with clinicopathological characteristics.
Zhou WN; Du YF; Zheng Y; Zhang W; Wu YN; Song XM; Bai J
Mol Med Rep; 2019 Feb; 19(2):885-894. PubMed ID: 30535462
[TBL] [Abstract][Full Text] [Related]
16. [Characteristics of occult cervical lymph node metastasis in squamous cell carcinoma of tongue and their influence on prognosis].
Yang AK; Chen FJ; Li QL; Wei MW; Song M
Ai Zheng; 2003 May; 22(5):541-4. PubMed ID: 12753722
[TBL] [Abstract][Full Text] [Related]
17. IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma.
Li HG; Han JJ; Huang ZQ; Wang L; Chen WL; Shen XM
J Craniofac Surg; 2011 Nov; 22(6):2022-5. PubMed ID: 22067851
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Kif2a promotes the progression and metastasis of squamous cell carcinoma of the oral tongue.
Wang CQ; Qu X; Zhang XY; Zhou CJ; Liu GX; Dong ZQ; Wei FC; Sun SZ
Oral Oncol; 2010 Jan; 46(1):65-9. PubMed ID: 20005768
[TBL] [Abstract][Full Text] [Related]
19. [Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue].
Chen WL; Zeng SG; Li HG; Huang HZ; Pan CB
Ai Zheng; 2002 Mar; 21(3):314-8. PubMed ID: 12452003
[TBL] [Abstract][Full Text] [Related]
20. CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.
Yu YH; Morales J; Feng L; Lee JJ; El-Naggar AK; Vigneswaran N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 May; 119(5):553-65. PubMed ID: 25747176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
